1.
Rev Med Interne
; 42(7): 517-518, 2021 07.
Article
in French
| MEDLINE | ID: covidwho-1294189
2.
Rev Med Interne
; 42(3): 227-228, 2021 03.
Article
in French
| MEDLINE | ID: covidwho-1096233
Subject(s)
COVID-19 Vaccines/therapeutic use , COVID-19/therapy , Immunotherapy, Active/adverse effects , SARS-CoV-2/immunology , Adolescent , Adult , Aged , Aged, 80 and over , BNT162 Vaccine , COVID-19/epidemiology , COVID-19 Vaccines/adverse effects , Clinical Trials as Topic/methods , Clinical Trials as Topic/organization & administration , Clinical Trials as Topic/standards , Female , Follow-Up Studies , Humans , Immunotherapy, Active/methods , Immunotherapy, Active/statistics & numerical data , Male , Middle Aged , Pandemics , Patient Safety/standards , RNA, Messenger/adverse effects , RNA, Messenger/therapeutic use , SARS-CoV-2/genetics , Treatment Outcome , Young Adult
3.
Rev Med Interne
; 41(11): 790-791, 2020 11.
Article
in French
| MEDLINE | ID: covidwho-882755